It is a tremendous honor to serve as Chair of ACC's Women in Cardiology (WIC) Member Section Leadership Council. I am deeply grateful to the visionary leaders who have built this extraordinary ...

A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure (SBP) by between ...

As part of its broader strategy to expand specialty participation in value-based care, the Centers for Medicare and Medicaid Services (CMS) has finalized a mandatory five-year Ambulatory Specialty ...

Artificial intelligence (AI) and digital technology advances have emerged as catalysts for changing how we diagnose, treat and manage patients. The following collection of AI resources has been ...

In the ABYSS (Assessment of Beta-Blocker Interruption 1 Year After an Uncomplicated Myocardial Infarction on Safety and Symptomatic Cardiac Events Requiring Hospitalization) trial, interruption of ...

The newest clinical guideline released by the ACC and the American Heart Association (AHA) provides new and updated recommendations for preventing and optimally managing atrial fibrillation (AFib).

The following are key points to remember from a review of lipoprotein(a) [Lp(a)] and cardiovascular disease (CVD): ...

About 50% of U.S. adults will develop high BP during their lifetime. High BP is the most prevalent and modifiable risk factor for cardiovascular disease and all-cause mortality. The overarching BP ...

Elite athletes and longevity: Evidence suggests that elite athletes generally live longer than the general population, with studies demonstrating lower mortality rates and reduced cardiovascular ...

The following are key points to remember from a state-of-the-art review on the benefits and drawbacks of vegetarian and vegan diets: ...

Lipoprotein(a) (Lp[a]) is a low-density lipoprotein–like molecule with an apolipoprotein (b) moiety that is covalently attached to apolipoprotein (a) (Apo[a]), a plasminogen-like protein that confers ...

Cardiovascular diseases (CVD) remain the leading cause of disease burden , causing one in three deaths worldwide as a result of population growth, population aging and exposure to a broad range of ...